4//SEC Filing
Andrews Nancy C 4
Accession 0001804999-25-000005
CIK 0001842295other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 4:13 PM ET
Size
5.5 KB
Accession
0001804999-25-000005
Insider Transaction Report
Form 4
Andrews Nancy C
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-09-22+18,000→ 18,000 totalExercise: $23.67Exp: 2035-09-21→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]The option shall vest as to 1/9 of the total award monthly with the first tranche vesting on October 1, 2025, subject to the reporting person's continued service to the Issuer on the applicable vesting date.
Documents
Issuer
Maze Therapeutics, Inc.
CIK 0001842295
Entity typeother
Related Parties
1- filerCIK 0001804999
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 4:13 PM ET
- Size
- 5.5 KB